| Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine V Oberhardt, H Luxenburger, J Kemming, I Schulien, K Ciminski, S Giese, ... Nature 597 (7875), 268-273, 2021 | 309 | 2021 |
| Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants S Weigang, J Fuchs, G Zimmer, D Schnepf, L Kern, J Beer, ... Nature communications 12 (1), 6405, 2021 | 144 | 2021 |
| Evolution and antiviral specificities of interferon-induced Mx proteins of bats against Ebola, influenza, and other RNA viruses J Fuchs, M Hölzer, M Schilling, C Patzina, A Schoen, T Hoenen, G Zimmer, ... Journal of virology 91 (15), 10.1128/jvi. 00361-17, 2017 | 66 | 2017 |
| IMU-838, a developmental DHODH inhibitor in phase II for autoimmune disease, shows anti-SARS-CoV-2 and broad-spectrum antiviral efficacy in vitro F Hahn, C Wangen, S Häge, AS Peter, G Dobler, B Hurst, J Julander, ... Viruses 12 (12), 1394, 2020 | 45 | 2020 |
| Impaired immune response drives age-dependent severity of COVID-19 J Beer, S Crotta, A Breithaupt, A Ohnemus, J Becker, B Sachs, L Kern, ... Journal of Experimental Medicine 219 (12), e20220621, 2022 | 37 | 2022 |
| Low Zika virus seroprevalence among pregnant women in North Central Nigeria, 2016 P Mathé, DZ Egah, JA Müller, NY Shehu, ET Obishakin, DD Shwe, ... Journal of Clinical Virology 105, 35-40, 2018 | 37 | 2018 |
| Antibody escape and global spread of SARS-CoV-2 lineage A. 27 T Kaleta, L Kern, SL Hong, M Hölzer, G Kochs, J Beer, D Schnepf, ... Nature communications 13 (1), 1152, 2022 | 24 | 2022 |
| Case series: convalescent plasma therapy for patients with COVID-19 and primary antibody deficiency J Lang-Meli, J Fuchs, P Mathé, H Ho, L Kern, L Jaki, G Rusignuolo, ... Journal of clinical immunology 42 (2), 253-265, 2022 | 22 | 2022 |
| Transmission characteristics, replication patterns and clinical manifestations of human monkeypox virus—an in-depth analysis of four cases from Germany D Hornuss, T Daehne, V Goetz, M Mueller, S Usadel, A Lorz, ... Clinical Microbiology and Infection 29 (1), 112. e5-112. e9, 2023 | 21 | 2023 |
| Essential role of interferon response in containing human pathogenic Bourbon virus J Fuchs, T Straub, M Seidl, G Kochs Emerging Infectious Diseases 25 (7), 1304, 2019 | 19 | 2019 |
| The landscape of SARS-CoV-2 RNA modifications M Miladi, J Fuchs, W Maier, S Weigang, ND Pedrosa, L Weiss, A Lother, ... Biorxiv, 2020.07. 18.204362, 2020 | 18 | 2020 |
| Molecular identification of novel phlebovirus sequences in European ticks M Prinz, J Fuchs, S Ehrmann, M Scherer-Lorenzen, G Kochs, M Panning Ticks and tick-borne diseases 8 (5), 795-798, 2017 | 16 | 2017 |
| External quality assessment of SARS-CoV-2 sequencing: an ESGMD-SSM pilot trial across 15 European laboratories F Wegner, T Roloff, M Huber, S Cordey, A Ramette, Y Gerth, C Bertelli, ... Journal of clinical microbiology 60 (1), e01698-21, 2022 | 15 | 2022 |
| Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants. Nat. Commun. 12, 6405 S Weigang, J Fuchs, G Zimmer, D Schnepf, L Kern, J Beer, ... | 14 | 2021 |
| Comparative Study of Ten Thogotovirus Isolates and Their Distinct In Vivo Characteristics J Fuchs, K Lamkiewicz, L Kolesnikova, M Hölzer, M Marz, G Kochs Journal of Virology 96 (5), e01556-21, 2022 | 12 | 2022 |
| Passive immunization against COVID-19 by anti-SARS-CoV-2 spike IgG in commercially available immunoglobulin preparations in severe antibody deficiency JR Hirsiger, S Weigang, AC Walz, J Fuchs, ML Daly, S Eggimann, ... The Journal of Allergy and Clinical Immunology: In Practice 10 (9), 2452 …, 2022 | 8 | 2022 |
| Tick-transmitted thogotovirus gains high virulence by a single MxA escape mutation in the viral nucleoprotein J Fuchs, A Oschwald, L Graf, G Kochs PLoS Pathogens 16 (11), e1009038, 2020 | 7 | 2020 |
| Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient L Jaki, S Weigang, L Kern, S Kramme, AG Wrobel, AB Grawitz, P Nawrath, ... Nature Communications 14 (1), 1999, 2023 | 5 | 2023 |
| Rapid and stable mobilization of fully functional spike-specific CD8+ T cells preceding a mature humoral response after SARS-CoV-2 mRNA vaccination R Thimme, V Oberhardt, H Luxenburger, J Kemming, I Schulien, ... | 4 | 2021 |
| The antiviral activity of equine Mx1 against Thogoto virus is determined by the molecular structure of its viral specificity region V Wagner, M Sabachvili, E Bendl, J Fuchs, G Kochs Journal of Virology 97 (2), e01938-22, 2023 | 3 | 2023 |
